Kritiserat bolag hotas av avnotering

Bio Vitos Pharma hotas av avnotering från Nasdaq efter anklagelser om bristande informationsgivning.

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

TECHNIA AB

Uppsalabolag riskerar avnotering – anklagas för bristande informationsgivning

Quia Pharma riskerar avnotering sedan Nasdaq påpekat vad som bedöms vara brister i informationsgivningen.

Börsnoterade Cyxone ansöker om konkurs

Cyxone, ett Malmöbaserat bioteknikföretag inom autoimmuna sjukdomar, meddelar att bolaget beslutat att ansöka om konkurs.

Pharma Outsourcing – Find the Right Partner (2026)

Corporate finance-bolag inom life science etablerar sig i Lund

North Point Securities, som arbetar med företagsfinansiering inom bland annat life science, etablerar sig i Lund.

Anna Törner: Yes, I Am Sick, But Not Weak

”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.

Efter misslyckade nyemissionen – Ziccum ansöker om konkurs

Det uppmärksammade Lundabolaget Ziccum, som utvecklat en metod för att torka biologiska läkemedel, har beslutat att ansöka om konkurs.

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

FDA approves new cystic fibrosis therapy

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Lilly´s Nordic manager on Mounjaro launch in Sweden: "Patients deserve respect"

Another blockbuster diabetes and obesity drug has made its way into the Swedish market – with promises of a stable supply and availability for patients. “What w...

Mathias Uhlén’s protein atlas is recognised as a global resource

The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...

The US is leaving the WHO

The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.

Bakterie som kan hejda malaria upptäckt av en slump

Forskare i Spanien har funnit en bakterieart som tycks ha malariadödande egenskaper.

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...

Trumps nya FDA-chef varnar för "massiv övermedicinering"

Donald Trump har nominerat kirurgen och författaren Marty Makary till ny chef för den amerikanska läkemedelsmyndigheten FDA, som enligt den tillträdande preside...

Controlled Pneumatics: pushing the boundaries of pneumatics

automation processes that are already known. It also opens up new opportunities, especially for controlling pressure and flow rate. Piezo valves, which enable v...

Scientific Solutions

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.